BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9579563)

  • 21. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K; Petersson M; Ciupitu AM; Wen T; Klein G; Kiessling R
    Cancer Res; 1995 Dec; 55(23):5648-55. PubMed ID: 7585649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes.
    Blake J; Johnston JV; Hellström KE; Marquardt H; Chen L
    J Exp Med; 1996 Jul; 184(1):121-30. PubMed ID: 8691125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large and dissimilar repertoire of Melan-A/MART-1-specific CTL in metastatic lesions and blood of a melanoma patient.
    Mandruzzato S; Rossi E; Bernardi F; Tosello V; Macino B; Basso G; Chiarion-Sileni V; Rossi CR; Montesco C; Zanovello P
    J Immunol; 2002 Oct; 169(7):4017-24. PubMed ID: 12244204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Skin-homing CD8+ T lymphocytes show preferential growth in vitro and suppress CD4+ T-cell proliferation in patients with early stages of cutaneous T-cell lymphoma.
    Thestrup-Pedersen K; Parhar R; Wu K; Bertilsson PA; Meyer B; Abu-Amero S; Hainau B; Aleisa A; Alfadley A; Hamadah I; Alajlan A; Al-Hussein K; Al-Mohanna F
    Acta Derm Venereol; 2007; 87(2):118-26. PubMed ID: 17340017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation and characterization of two human alpha/beta T cell clones. Recognizing autologous breast tumor cells through an HLA- and TCR/CD3-independent pathway.
    Nisticò P; De Berardinis P; Morrone S; Alonzi T; Buono C; Venturo I; Natali PG
    J Clin Invest; 1994 Oct; 94(4):1426-31. PubMed ID: 7929817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of conserved T cell receptor CDR3 residues contacting known exposed peptide side chains from a major histocompatibility complex class I-bound determinant.
    Kelly JM; Sterry SJ; Cose S; Turner SJ; Fecondo J; Rodda S; Fink PJ; Carbone FR
    Eur J Immunol; 1993 Dec; 23(12):3318-26. PubMed ID: 8258346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile.
    Querfeld C; Leung S; Myskowski PL; Curran SA; Goldman DA; Heller G; Wu X; Kil SH; Sharma S; Finn KJ; Horwitz S; Moskowitz A; Mehrara B; Rosen ST; Halpern AC; Young JW
    Cancer Immunol Res; 2018 Aug; 6(8):900-909. PubMed ID: 29895574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-infiltrating lymphocytes isolated from a Ki-1-positive large cell lymphoma of the skin. Phenotypic characterization and analysis of cytokine secretion.
    Reinhold U; Abken H; Kukel S; Goeden B; Uerlich M; Neumann U; Kreysel HW
    Cancer; 1991 Nov; 68(10):2155-60. PubMed ID: 1655203
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T Cells Engaging the Conserved MHC Class Ib Molecule Qa-1
    Doorduijn EM; Sluijter M; Querido BJ; Seidel UJE; Oliveira CC; van der Burg SH; van Hall T
    Front Immunol; 2018; 9():60. PubMed ID: 29422902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.
    Horiguchi Y; Nukaya I; Okazawa K; Kawashima I; Fikes J; Sette A; Tachibana M; Takesako K; Murai M
    Clin Cancer Res; 2002 Dec; 8(12):3885-92. PubMed ID: 12473604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous cellular and humoral immune response against mutated p53 in a patient with lung cancer.
    Ichiki Y; Takenoyama M; Mizukami M; So T; Sugaya M; Yasuda M; So T; Hanagiri T; Sugio K; Yasumoto K
    J Immunol; 2004 Apr; 172(8):4844-50. PubMed ID: 15067062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The TCR repertoire of an immunodominant CD8+ T lymphocyte population.
    Chen ZW; Li Y; Zeng X; Kuroda MJ; Schmitz JE; Shen Y; Lai X; Shen L; Letvin NL
    J Immunol; 2001 Apr; 166(7):4525-33. PubMed ID: 11254709
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Blümel E; Munir Ahmad S; Nastasi C; Willerslev-Olsen A; Gluud M; Fredholm S; Hu T; Surewaard BGJ; Lindahl LM; Fogh H; Koralov SB; Rahbek Gjerdrum LM; Clark RA; Iversen L; Krejsgaard T; Bonefeld CM; Geisler C; Becker JC; Woetmann A; Andersen MH; Buus TB; Ødum N
    Oncoimmunology; 2020; 9(1):1751561. PubMed ID: 32363124
    [No Abstract]   [Full Text] [Related]  

  • 35. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant and normal T cells show random use of T-cell receptor alpha chain variable regions in patients with cutaneous T-cell lymphoma.
    Longley J; Tyrrell L; Lu SZ; Farrell J; Ding TG; Yan S; Sallee D; Heald P; Berger C; Tigelaar R
    J Invest Dermatol; 1995 Jul; 105(1):62-4. PubMed ID: 7615977
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functionally impaired HIV-specific CD8 T cells show high affinity TCR-ligand interactions.
    Ueno T; Tomiyama H; Fujiwara M; Oka S; Takiguchi M
    J Immunol; 2004 Nov; 173(9):5451-7. PubMed ID: 15494492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
    Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
    Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD8(+) granulomatous cutaneous T-cell lymphoma: a potential association with immunodeficiency.
    Gammon B; Robson A; Deonizio J; Arkin L; Guitart J
    J Am Acad Dermatol; 2014 Sep; 71(3):555-60. PubMed ID: 24813299
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of conserved CDR3 sequence of TCR alpha- and beta-chain genes in peripheral blood T-cells from patients with diffuse large B-cell lymphoma.
    Yin Q; Tan H; Chen S; Yang L; Ye J; Li Y
    Hematology; 2010 Feb; 15(1):48-57. PubMed ID: 20132663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.